Photo Rounds

Acute unilateral visual disturbance

Author and Disclosure Information

 

References

Treatment may include injections, surgery, or nothing at all

Currently, there are no proven treatments to reopen occluded retinal veins. Thus, management is directed at complications that contribute to vision loss, including macular edema and neovascularization.20-21 Intravitreal anti-vascular endothelial growth factor (VEGF) agents are recognized as first-line therapy for macular edema in numerous studies.22-26 Intravitreal corticosteroids are an alternative treatment for patients with macular edema who do not respond to anti-VEGF therapy; however, monitoring is required as these corticosteroids increase the risk for glaucoma and cataract formation.27 In patients with CRVO with neovascularization, panretinal laser photocoagulation may be used.28

Observation and monitoring for the development of complications, rather than initiation of treatment, is appropriate for patients with CRVO without macular edema or neovascularization, with follow-up intervals and duration dictated by the severity of visual loss and whether the CRVO was ischemic or nonischemic.

Our patient’s diagnosis was confirmed by retinal specialists with optic coherence tomography, gonioscopy, and fluorescein angiography. He underwent an extensive laboratory work-up and hypercoagulation studies to determine the etiology. All results returned within normal limits with the exception of a nonspecific pattern found on serum protein electrophoresis that suggested dehydration.

Observation and monitoring for the development of complications is appropriate for patients with central retinal vein occlusion without macular edema.

Given his negative hypercoagulation studies, normal laboratory values, and new exercise regimen, dehydration was concluded to be the likely etiology. Since his visual acuity was not affected, observation with bimonthly follow-up for 6 months was the management strategy. He was also encouraged to maintain adequate hydration during exercise. His vision returned to normal 2 weeks after the initial event, and he did not have recurrence during the monitoring period.

Pages

Recommended Reading

Sweaty treatment for social anxiety could pass the sniff test
MDedge Family Medicine
FDA panels vote to modify isotretinoin iPLEDGE REMS
MDedge Family Medicine
‘Excess’ deaths surging, but why?
MDedge Family Medicine
Frustration over iPLEDGE evident at FDA meeting
MDedge Family Medicine
Deadly bacteria in recalled eye drops can spread person-to-person
MDedge Family Medicine
Lack of food for thought: Starve a bacterium, feed an infection
MDedge Family Medicine
Clinical Practice Update: Alpha-gal syndrome often causes GI issues without anaphylaxis, skin changes
MDedge Family Medicine
Study highlights potential skin cancer risk of UV nail polish dryers
MDedge Family Medicine
Hyperlipidemia management: A calibrated approach
MDedge Family Medicine
One emergency is ending, and we’re ready for the next
MDedge Family Medicine